Table 3 Viability of embedded sand fleas in the treatment groups at baseline and the subsequent follow-ups^a

Baseline (day 0)

All lesions

139

0

100

146

0

100

n.a.

stage 2

126

0

100

132

0

100

n.a.

stage 3

13

0

100

14

0

100

n.a.

First follow-up (day 2)

All lesions

32

105

23.4

10

132

7.0

<0.001

stage 2

31

92

25.2

8

116

6.5

<0.001

stage 3

1

13

7.1

2

16

11.1

0.600

Second follow-up (day 5)

All lesions

15

105

12.5

5

122

3.9

0.018

stage 2

14

95

12.8

5

109

4.4

0.030

stage 3

1

10

9.1

0

13

0

0.458

Third follow-up (day 7)

All lesions

6

128

4.5

3

137

2.1

0.326

stage 2

5

115

4.2

3

120

2.4

0.496

stage 3

1

13

7.1

0

17

0.0

0.452